semaglutide heart failure fda approves weight-loss drug Wegovy to reduce heart-disease risks FDA Clears Semaglutide For Cardiac

Common cardiovascular effects include tachycardia, palpitations, and elevated blood pressure

Semaglutide is a peptide-based medication with a complex three-dimensional protein structure that is sensitive to thermal degradation

Semaglutide GLP-1 vs Tirzepatide for Weight Loss in Adults with Obesity or are Overweight Q&A At JuicyFace, our board-certified internal medicine physician Purnima Balla, M.D., provides expert guidance on weight loss solutions, including semaglutide GLP-1 and tirzepatide

7.3 Prospects Therefore, given the current situation and the challenges of insufficient clinical research, inconsistent efficacy, and unclear side effects, it is proposed that future efforts should focus on conducting large-scale, multicenter clinical studies to validate long-term efficacy, as well as research on drug side effects and dosage optimization